Evidence map›Paper›PMID 31981154›Full record

ReviewJournal of ultrasound2021

Delayed contrast enhancement of hepatic parenchyma after intravenous sonographic contrast agent: unusual phenomenon. Case report and review of literature.

David Laszlo Tarnoki, Adam Domonkos Tarnoki, Hunor Sukosd, Aniko Folhoffer, Zoltan Harkanyi

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of ultrasound, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

David Laszlo TarnokiDepartment of Medical Imaging, Semmelweis University, Budapest, Hungary. tarnoki4@gmail.com.ORCID http://orcid.org/0000-0002-7001-7647
Adam Domonkos TarnokiDepartment of Medical Imaging, Semmelweis University, Budapest, Hungary.
Hunor SukosdDepartment of Medical Imaging, Semmelweis University, Budapest, Hungary.
Aniko Folhoffer1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
Zoltan HarkanyiDepartment of Radiology, Heim Pál Childrens Hospital, Budapest, Hungary.
Semmelweis University · HUHeim Pál Országos Gyermekgyógyászati Intézet · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimA case of heterogeneous late-phase hepatic enhancement (HLHE) using contrast-enhanced ultrasound (CEUS) with SonoVue is presented, where HLHE lasted after 50 min of injection.

methodsThis study aims to review prior literature on this topic, to characterize the features of HLHE in the liver, and to find possible and reliable explanations for this phenomenon.

resultsFrom literature, thus far five publications discuss this phenomenon with a total of 21 patients.

conclusionWe suggest that phagocytosis of contrast agent microbubbles by macrophages, and lymphocytosis of peripheral blood due to stress conditions of the patients might be in the background of HLHE.

Indexed as

Liver NeoplasmsContrast MediaHumansMicrobubblesParenchymal TissuePhospholipidsSulfur HexafluorideUltrasonographyContrast MediaPhospholipidsSulfur HexafluorideContrast enhanced ultrasoundDelayed contrast enhancementSonography

Identifiers

PMID31981154
PMCPMC7925801
OpenAlexW3001887071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.